Key Account Manager – Rare Disease, Pediatric Endocrinology

🔥 3 hours ago

Apply Now

Find Similar Remote Jobs

Set Up Email Alert For New Jobs

📊 Check your resume score for this job

Improve your chances of getting an interview by checking your resume score before you apply.

Upload Resume

Egetis Therapeutics

WebsiteLinkedInAll Job Openings

11 - 50 employees

💊 Pharmaceuticals

🧬 Biotechnology

Pharmaceuticals • Biotechnology

Egetis is an innovative, integrated pharmaceutical company focused on late-stage development and commercialization of treatments for serious diseases with significant unmet medical needs, particularly in the orphan drug segment. The company's lead product candidate is Emcitate (tiratricol) for MCT8 deficiency/Allan‑Herndon‑Dudley syndrome; its pipeline also includes Aladote for acetaminophen (paracetamol) overdose. Headquartered in Stockholm, Sweden, Egetis positions itself around development, regulatory interaction and market access for rare-disease therapeutics.

📋 Description

• - Identify, prioritize and establish deep relationships with target pediatric endocrinology and neurology centers and referral sites for Egetis product, including leading the transition of patients from early access to commercial product • - Execute pre-launch and launch activities across assigned targeted HCP and accounts to driver appropriate awareness, adoption and sustained utilization of Egetis therapies. • - Lead disease state education efforts, including diagnostic testing, across all customer stakeholders in a very low-prevalence and low-awareness market environment • - Lead comprehensive patient finding/identification efforts by combining targeted disease education, sophisticated use of ICD-10/CPT Code and claims/EMR data and navigation of complex HCP referral patterns • - Develop and execute detailed territory plans including individual key customer strategies and tactics, leveraging data and insights to continuously refine priorities and resource allocation. • - Position Egetis as a long-term partner withing the rare diseases community. Educate all customer stakeholders on the services and support that Egetis provides to accounts and to the patient community, including but not limited to market access support, patient services programs and disease education initiatives. • - Demonstrate cross functional leadership by working closely and collaboratively with Marketing, Medical Affairs, Market Access, Patient Services, Business Operations and Senior Leadership • - Provide rapid, structured field insights to shape launch strategies, materials, and support programs and actively participate in internal decision making forums to inform strategy, well beyond traditional sales responsibilities • - Own territory business performance by tracking and managing key metrics (e.g., patient starts, account activation, and other agreed KPIs) and maintaining accurate, timely documentation in CRM and other reporting tools. • - Help establish field norms and launch playbooks for the organization • - Maintain high compliance standards despite startup pace and ambiguity

🎯 Requirements

• - Bachelor’s degree required • - 10+ years of pharmaceutical or biotech sales experience required • - Experience in rare or ultra-rare disease is required with demonstrated ability to navigate very low-prevalence, low awareness markets. • - Prior first-launch or early-stage biotech experience is preferred • - Experience with selling in Children’s Hospital’s, pediatric endocrinology and/or neurology is preferred • - Proven success operating independently within a large geographic territory with limited resources, acting as a primary business owner for the region • - Strong clinical understanding and ability to engage credibly with academic specialists • - High level of comfort with ambiguity, travel intensity, and direct leadership exposure • - Patient centric with high ethical standards • - Demonstrating a high level of cross functional collaboration. • - Solid understanding of US legal, regulatory and compliance requirements • Travel Requirements** • - Up to 60–70% travel due to large territories